Prospective, Randomized, Double-Blind, Phase III Clinical Trial of Anti-T-Lymphocyte Globulin to Assess Impact on Chronic Graft-Versus-Host Disease-Free Survival in Patients Undergoing HLA-Matched Unrelated Myeloablative Hematopoietic Cell Transplan
about
From remission to cure: bypass or detour?Chronic Graft-versus-Host Disease: A Long Road Ahead.Bortezomib-based immunosuppression after reduced-intensity conditioning hematopoietic stem cell transplantation: randomized phase II results.Ex vivo and in vivo T cell-depleted allogeneic stem cell transplantation in patients with acute myeloid leukemia in first complete remission resulted in similar overall survival: on behalf of the ALWP of the EBMT and the MSKCCComputational modeling and confirmation of leukemia-associated minor histocompatibility antigensHow ibrutinib, a B-cell malignancy drug, became an FDA-approved second-line therapy for steroid-resistant chronic GVHD
P2860
Prospective, Randomized, Double-Blind, Phase III Clinical Trial of Anti-T-Lymphocyte Globulin to Assess Impact on Chronic Graft-Versus-Host Disease-Free Survival in Patients Undergoing HLA-Matched Unrelated Myeloablative Hematopoietic Cell Transplan
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Prospective, Randomized, Doubl ...... e Hematopoietic Cell Transplan
@en
Prospective, Randomized, Doubl ...... e Hematopoietic Cell Transplan
@nl
type
label
Prospective, Randomized, Doubl ...... e Hematopoietic Cell Transplan
@en
Prospective, Randomized, Doubl ...... e Hematopoietic Cell Transplan
@nl
prefLabel
Prospective, Randomized, Doubl ...... e Hematopoietic Cell Transplan
@en
Prospective, Randomized, Doubl ...... e Hematopoietic Cell Transplan
@nl
P2093
P356
P1476
Prospective, Randomized, Doubl ...... e Hematopoietic Cell Transplan
@en
P2093
Andrew Artz
David L Porter
Edwin P Alyea
Frank Glavin
Haesook T Kim
Hana Safah
Ian D Lewis
James D Levine
Jennifer Holter
P304
P356
10.1200/JCO.2017.75.8177
P407
P577
2017-10-17T00:00:00Z